CORBF Stock: Global Cord Blood Corporation Stock Price, Analysis & Insights
Get live CORBF stock price $0.95, comprehensive Global Cord Blood Corporation stock analysis, charts, news, and expert forecast. Real-time CORBF stock data and investment insights.
Loading chart data...
Global Cord Blood Corporation (CORBF) Overview
Global Cord Blood Corporation (CORBF) is a publicly traded company in the Healthcare sector , specifically within the Medical - Diagnostics & Research industry . As of the latest trading session, CORBF trades at $0.95 with a market capitalization of 127.22M . Over the past 52 weeks, CORBF has traded between $0.20 and $1.75 , with the current price positioned at approximately 48% of this range ....
Key Takeaways
- Operates in the Healthcare sector (Medical - Diagnostics & Research)
- Market cap: 127.22M
- Current price: $0.95
- 52-week range: $0.20 - $1.75
- P/E ratio: 2.71
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Global Cord Blood Corporation, headquartered in Central, Hong Kong, primarily offers umbilical cord blood preservation and related support services within the People's Republic of China. The company's operations include the comprehensive testing, pro...
Company Information
- CEO
- Ting Zheng
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 1202
Contact Information
- Address
- Bank of China Tower
- Country
- HK
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 2.7)
✓ Lower volatility stock (Beta: -0.77) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Global Cord Blood Corporation shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Global Cord Blood Corporation
- ⚠Investors should consider how Global Cord Blood Corporation fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
127.22M
P/E Ratio (TTM)
2.71
Beta
-0.77
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare CORBF with peer companies:
- Price
- $32.50
- Market cap
- 29.07M
- Price
- $0.03
- Market cap
- 14.48M
- Price
- $0.15
- Market cap
- 38.57M
- Price
- $0.00
- Market cap
- 88.89K
- Price
- $0.00
- Market cap
- 32.07M
- Price
- $0.37
- Market cap
- 41.68M
- Price
- $0.48
- Market cap
- 34.77M
- Price
- $0.06
- Market cap
- 29.88M
- Price
- $0.11
- Market cap
- 38.25M
- Price
- $0.00
- Market cap
- 6.76K
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.